Search Results
Jun 01, 2026, 13:11 ET 5 Facts About Health Savings Accounts (HSAs) and Newly Released IRS 2027 HSA Contribution Limits from the Experts at HSA Store®
out-of-pocket maximums for high-deductible health plans (HDHPs) will also increase in 2027. Before opening an HSA, account holders should check with their HR team or health plan to confirm that their plan is compatible and eligible for HSA enrollment.5 Little-known Facts about HSA ContributionsHere
More news about: Health-E Commerce
Jun 01, 2026, 11:00 ET IDEAYA Biosciences and Servier Provide Complete Data from Phase 2/3 Registrational OptimUM-02 Trial of the Darovasertib Combination in First Line HLA*A2:01 Negative Metastatic Uveal Melanoma in a Late-Breaking Oral Presentation at ASCO
months in the ICT arm by BICR (HR: 0.42; 95% CI: 0.30, 0.59; p-value: <0.0001).Patients treated with the darovasertib combination also had a statistically significant improvement in median PFS of 6.7 months versus 2.7 months for ICT by investigator assessment (HR: 0.36; 95% CI: 0.26, 0.50, p-value:
More news about: IDEAYA Biosciences, Inc.
Jun 01, 2026, 09:24 ET Promising Phase 1 Data for Servier's Emiltatug Ledadotin (Emi-Le) in Adenoid Cystic Carcinoma (ACC) Presented at ASCO 2026
metastatic triple-negative breast cancer, and 2) advanced or metastatic HER2 low / HER2 negative breast cancer post-topo-1 ADC (including TNBC and certain HR+ breast cancers). It has also received Breakthrough Designation from the FDA for the treatment of patients with locally advanced, recurrent or metastatic
More news about: Servier Pharmaceuticals
Jun 01, 2026, 09:00 ET Chamberlain Group Welcomes Michelle Bonfilio as Chief Human Resources Officer
next chapter. She is exactly the right person for this moment," said Jeff Meredith, CEO of Chamberlain Group.Bonfilio brings extensive HR leadership experience across public and private organizations. Most recently, she served as CHRO at Help at Home, where she guided the organization through
More news about: Chamberlain Group
Jun 01, 2026, 09:00 ET Lossdog Gives New Graduates Access to the Workforce Data Employers Already Rely On
workers.Tom Sosnoff, Co-Founder and Co-CEO said, "The company hiring you already knows exactly what your market value is before you walk into the interview. HR departments benchmark compensation, analyze labor-market data, and model salary bands in real time. Most graduates are still negotiating the most financially
More news about: Lossdog
Jun 01, 2026, 08:52 ET BD&J Achieves Stunning $3 Billion in Recoveries for California Personal Injury Clients
our mission of helping as many Californians as possible receive as much in compensation as possible to heart. Everyone in the BD&J family – from HR to Paralegals – had a part to play and we're so appreciative of their hard work and our clients' trust."About BD&J, PC: BD&J, PC,
More news about: BD&J, PC
Jun 01, 2026, 08:05 ET SHARx CEO Warns Companies May Be Overlooking Their Biggest Cost Driver in Healthcare
called this the highest projected employer health cost growth in 15 years.According to Durbin, many organizations still treat healthcare as a fixed HR expense rather than a controllable financial risk, even as rising pharmacy costs increasingly affect budgeting, forecasting, hiring plans, and long-term
More news about: SHARx
Jun 01, 2026, 07:05 ET Drake International Marks 75th Anniversary with Investment in Canada's Future Workforce
through Workforce Solutions (flexible staffing, permanent recruitment, on-site services), Certification, Assessment and Training, Health and Wellbeing, HR Advisory, and Drake Ventures. www.drakeinternational.comAbout Drake Force for
More news about: Drake International
Jun 01, 2026, 06:19 ET Kenon Holdings Reports Q1 2026 Results and Additional Updates
(EPC) agreement for the construction of a solar power plant with an estimated installed capacity of 550 MW with integrated storage of about 3,850 megawatts/hr, with a total cost of approximately $158 million - $160 million.Signing of agreement for supply of electricity to data centers in IsraelIn
More news about: Kenon Holdings Ltd.
Jun 01, 2026, 06:01 ET A combined therapeutic strategy aims to improve disease control in advanced hormone‑sensitive prostate cancer
international phase II trial evaluating the efficacy and safety of combining the SERD camizestrant with the CDK4/6 inhibitor ribociclib in patients with advanced HR+/HER2‑ breast cancer who have stopped responding to standard treatments. The study, currently ongoing at centers in Spain, Germany, and China, includes
More news about: MEDSIR
May 31, 2026, 09:00 ET HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Session
of PD-L1 expression status: HR=0.68 in the PD-L1 TPS ≥1% subgroup and HR=0.64 in the TPS <1% subgroup; HR=0.67 in the PD-L1 TPS 1–49% subgroup and HR=0.64 in the TPS ≥50% subgroup.The OS benefit was also consistent across subgroups defined by metastatic burden: HR=0.47 in patients with ≥3 metastatic
More news about: Akeso, Inc.
May 31, 2026, 08:27 ET Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm
in the risk of metastasis or death (hazard ratio [HR], 0.80; 95 percent CI, 0.67-0.96; p=0.02), with five-year rates of 78.2 percent versus 73.5 percent, respectively. Similar metastasis-free survival results were observed in investigator assessments (HR, 0.74; 95 percent CI, 0.62-0.87; p=0.0004).1Key
More news about: Johnson & Johnson
May 31, 2026, 08:01 ET Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer
EFS in the primary analysis population (patients with stage II-IIIA disease, n=109) was significantly improved with selpercatinib compared to placebo (HR: 0.17 [95% CI, 0.06 to 0.51]; p<0.001). The EFS rate at 24 months was 92% [95% CI, 75.4 to 97.2] for selpercatinib compared to 61% [95% CI, 44.2 to
More news about: Eli Lilly and Company
May 30, 2026, 20:00 ET Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet
sac-TMT and pembrolizumab significantly prolongs progression-free survival (PFS) and reduces the risk of disease progression or death, with a hazard ratio (HR) of 0.35. Consistent PFS benefits were observed across all prespecified subgroups, including by PD-L1 expression level and histological type, with PFS
More news about: Kelun-Biotech
May 30, 2026, 08:05 ET ROADS Phase 3 Clinical Trial Data Presented at ASCO26 Show GammaTile® Provides Superior Tumor Control Leading to Patients Living Longer Without Recurrence Compared to Standard of Care in Newly Diagnosed Operable Brain Metastases
11.9%).Patients who received GammaTile had a greater than 50% reduction in risk of either tumor recurrence or death compared to standard of care [SRT] (HR: 0.48, p=0.002).GammaTile provided benefit in key secondary endpoints1The
More news about: GT Medical Technologies
May 29, 2026, 23:32 ET The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet
pembrolizumab compared with pembrolizumab alone. The median PFS assessed by blinded independent central review (BICR) was not reached (NR) vs 5.7 months (HR=0.35; 95% CI: 0.26-0.47; p<0.0001). The 12-month PFS rate was 62.4% vs 29.0%.
More news about: Kelun-Biotech
May 29, 2026, 11:21 ET Enterprise Application Support Teams Risk Falling Behind Cloud Delivery Without Skill Realignment, Says Info-Tech Research Group
Info-Tech Research Group is the "get things done" partner for over 30,000 IT, HR, and marketing leaders worldwide. The fastest growing research and advisory firm, Info-Tech enables leaders to make well-informed decisions and transform
More news about: Info-Tech Research Group
May 29, 2026, 10:00 ET Hankook Tire Receives Honda's '2025 Supplier Excellence Award'
maintained a strong partnership with Honda since 2013 and currently supplies original equipment tires for Honda's key SUV lineup, including the CR-V, HR-V, Pilot, and Passport, as well as major global sedan models such as the Accord and Civic. Building on this recognition, Hankook Tire plans to further
More news about: Hankook Tire America Corp.
May 29, 2026, 09:01 ET Vensure Launches Sports & Entertainment Division to Support the Demands of Dynamic Workforces
Tailored payroll, HR, and compliance support for sports teams, productions, and live event operators.CHANDLER, Ariz., May 29, 2026 /PRNewswire/ -- Vensure Employer Solutions (Vensure), a leading provider of HR/HCM technology,
More news about: Vensure Employer Solutions
May 29, 2026, 08:52 ET Dizal Announces Phase 3 WU-KONG28 Results: ZEGFROVY® (Sunvozertinib) Outperforms Platinum-Doublet Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer
Median PFS was 10.3 months with ZEGFROVY versus 7.5 months with chemotherapy (HR=0.65; P=0.0008).BICR-assessed best objective response rate (BoR) was 68.1% with ZEGFROVY versus 35.4%
More news about: Dizal Pharmaceutical
May 29, 2026, 08:18 ET New TECVAYLI® (teclistamab-cqyv) data demonstrate superior progression-free and overall survival as early as first relapse in multiple myeloma
TECVAYLI® demonstrated a 71% reduction in the risk of disease progression or death (hazard ratio [HR]=0.29; 95% confidence interval [CI], 0.23, 0.38) and a 40% reduction in the risk of death (HR=0.60; 95% CI, 0.43, 0.83)] compared to standard of care, demonstrating significant improvements in both PFS
More news about: Johnson & Johnson
May 28, 2026, 16:05 ET RED ROBIN GOURMET BURGERS, INC. ANNOUNCES REFRANCHISING AGREEMENT TO SUPPORT "FIRST CHOICE PLAN"
national brands over nearly three decades. With more than 1,200 employees across their operating entities and a support center providing accounting, HR, IT, marketing, payroll, purchasing, and real estate services, the team brings organizational depth to support the 30 Red Robin locations from day one.Dave
More news about: Red Robin Gourmet Burgers, Inc.
May 28, 2026, 13:23 ET Group Management Services Celebrates 30 Years of Empowering Businesses
simplifying workforce management.Today, GMS delivers full-service HR outsourcing through a co-employment model that includes human resources, payroll, benefits administration, and risk management support. By combining experienced HR professionals with technology-enabled solutions, GMS helps employers
More news about: Group Management Services, Inc.
May 28, 2026, 11:13 ET Info-Tech LIVE 2026 in Las Vegas to Feature IT Playbook Sessions on Achieving IT Excellence
Info-Tech Research Group is one of the world's leading and fastest-growing research and advisory firms, serving over 30,000 IT, HR, and marketing professionals around the globe. As a trusted product and service leader, the company delivers unbiased, highly relevant research and industry-leading
More news about: Info-Tech Research Group
May 28, 2026, 11:13 ET Info-Tech LIVE 2026 in Las Vegas to Feature IT Playbook Sessions on Achieving IT Excellence
Info-Tech Research Group is one of the world's leading and fastest-growing research and advisory firms, serving over 30,000 IT, HR, and marketing professionals around the globe. As a trusted product and service leader, the company delivers unbiased, highly relevant research and industry-leading
More news about: Info-Tech Research Group